Loading...
Loading...
India's diltiazem imports from UNITED STATES total $155.5K across 112 shipments from 15 foreign suppliers. AMSTERDAM PHARMA (APTEKA RX INC.) leads with $30.1K in import value; the top 5 suppliers together control 55.4% of this origin. Leading Indian buyers include MACLEODS PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for diltiazem — a diversified sourcing base with multiple active suppliers from UNITED STATES.

AMSTERDAM PHARMA (APTEKA RX INC.) is the leading Diltiazem supplier from UNITED STATES to India, with import value of $30.1K across 5 shipments. The top 5 suppliers — AMSTERDAM PHARMA (APTEKA RX INC.), ACTAVIS LABORATORIES FL INC., Spring Bio Solution, NEW LIFE MEDICALS (USA) INC., NEWLIFE MEDICALS (USA) INC — collectively account for 55.4% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMSTERDAM PHARMA (APTEKA RX INC.) | $30.1K | 5 | 19.3% |
| 2 | ACTAVIS LABORATORIES FL INC. | $15.7K | 14 | 10.1% |
| 3 | Spring Bio Solution | $14.1K | 9 | 9.1% |
| 4 | NEW LIFE MEDICALS (USA) INC. | $14.0K | 3 | 9.0% |
| 5 | NEWLIFE MEDICALS (USA) INC | $12.2K | 2 | 7.9% |
| 6 | NEWLIFE MEDICALS (USA). INC. | $11.9K | 2 | 7.7% |
| 7 | RAFF AND HALL PHARMACY | $10.9K | 3 | 7.0% |
| 8 | ESPEE BIOPHARMA & FINECHEM LLC | $8.2K | 6 | 5.3% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES INC. | $5.5K | 4 | 3.5% |
| 10 | Good Health Pharma Supplies | $4.0K | 3 | 2.5% |
| 11 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $3.6K | 10 | 2.3% |
| 12 | RAFF HALL PHARMACY | $3.4K | 3 | 2.2% |
| 13 | AMSTERDAM PHARMA(APTEKA RX INC.) | $2.3K | 1 | 1.5% |
| 14 | ESPEE BIOPHARMA & FINECHEM LLC. | $2.3K | 1 | 1.5% |
| 15 | SPRING BIO SOLUTION | $1.5K | 6 | 1.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | $26.1K | 1 | 16.8% |
| 2 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $16.3K | 15 | 10.5% |
| 3 | ZYDUS LIFESCIENCES LIMITED | $15.0K | 3 | 9.6% |
| 4 | LAURUS LABS LIMITED | $14.5K | 12 | 9.3% |
| 5 | CLIANTHA RESEARCH LIMITED | $12.8K | 3 | 8.2% |
| 6 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $9.7K | 3 | 6.3% |
| 7 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $9.6K | 8 | 6.2% |
| 8 | MANKIND PHARMA LIMITED | $8.5K | 1 | 5.5% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.0K | 6 | 3.8% |
| 10 | AJANTA PHARMA LIMITED | $5.7K | 6 | 3.7% |
| 11 | PAR FORMULATIONS PRIVATE LIMITED | $5.6K | 13 | 3.6% |
| 12 | XYLOPIA LABS PRIVATE LIMITED | $4.0K | 11 | 2.6% |
| 13 | HETERO LABS LIMITED | $4.0K | 3 | 2.5% |
| 14 | APPCURE LABS PRIVATE LIMITED | $3.7K | 3 | 2.4% |
| 15 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $2.4K | 2 | 1.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Diltiazem suppliers from UNITED STATES to India include AMSTERDAM PHARMA (APTEKA RX INC.), ACTAVIS LABORATORIES FL INC., Spring Bio Solution. The leading supplier is AMSTERDAM PHARMA (APTEKA RX INC.) with import value of $30.1K USD across 5 shipments. India imported Diltiazem worth $155.5K USD from UNITED STATES in total across 112 shipments.
India imported Diltiazem worth $155.5K USD from UNITED STATES across 112 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Diltiazem sourced from UNITED STATES include MACLEODS PHARMACEUTICALS LTD, ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED. The largest buyer is MACLEODS PHARMACEUTICALS LTD with $26.1K in imports across 1 shipments.
The total value of Diltiazem imports from UNITED STATES to India is $155.5K USD, across 112 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
112 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists